ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Resverlogix Corp

Resverlogix Corp (RVX)

0,05
0,00
( 0,00% )
Aktualisiert: 01:00:00

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,05
Gebot
0,05
Fragen
0,055
Volumen
45.000
0,05 Tagesbereich 0,05
0,04 52-Wochen-Bereich 0,095
Marktkapitalisierung
Handelsende
0,05
Handelsbeginn
0,05
Letzte Trade
15000
@
0.05
Letzter Handelszeitpunkt
21:03:58
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
60.009
Ausgegebene Aktien
272.371.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,81
Gewinn pro Aktie (EPS)
-0,06
Erlöse
57k
Nettogewinn
-16,74M

Über Resverlogix Corp

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Calgary, Alberta, Can
Gegründet
-
Resverlogix Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Börse with ticker RVX. The last closing price for Resverlogix was $0,05. Over the last year, Resverlogix shares have traded in a share price range of $ 0,04 to $ 0,095.

Resverlogix currently has 272.371.000 shares in issue. The market capitalisation of Resverlogix is $13,62 million. Resverlogix has a price to earnings ratio (PE ratio) of -0.81.

RVX Neueste Nachrichten

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s...

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to...

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse...

Resverlogix Announces Appointment of New Chief Scientific Officer

CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr...

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the “Meeting”) in Calgary...

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D...

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug...

Resverlogix Announces One-Year Extension of Debenture

CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0...

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary...

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global leader in the development of epigenetic therapeutics, today announced that Donald...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.050.0550.0598000.05294892CS
4-0.005-9.090909090910.0550.060.05398370.05569775CS
12-0.01-16.66666666670.060.0650.05600090.05606776CS
26-0.005-9.090909090910.0550.0950.045848580.06800966CS
52-0.02-28.57142857140.070.0950.04565180.0651836CS
156-0.62-92.53731343280.670.740.04668910.1499659CS
260-1.3-96.29629629631.351.520.04640650.41029684CS

RVX - Frequently Asked Questions (FAQ)

What is the current Resverlogix share price?
The current share price of Resverlogix is $ 0,05
How many Resverlogix shares are in issue?
Resverlogix has 272.371.000 shares in issue
What is the market cap of Resverlogix?
The market capitalisation of Resverlogix is CAD 13,62M
What is the 1 year trading range for Resverlogix share price?
Resverlogix has traded in the range of $ 0,04 to $ 0,095 during the past year
What is the PE ratio of Resverlogix?
The price to earnings ratio of Resverlogix is -0,81
What is the cash to sales ratio of Resverlogix?
The cash to sales ratio of Resverlogix is 250
What is the reporting currency for Resverlogix?
Resverlogix reports financial results in USD
What is the latest annual turnover for Resverlogix?
The latest annual turnover of Resverlogix is USD 57k
What is the latest annual profit for Resverlogix?
The latest annual profit of Resverlogix is USD -16,74M
What is the registered address of Resverlogix?
The registered address for Resverlogix is 4820 RICHARD ROAD S.W, SUITE 300, CALGARY, ALBERTA, T3E 6L1
What is the Resverlogix website address?
The website address for Resverlogix is www.resverlogix.com
Which industry sector does Resverlogix operate in?
Resverlogix operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ACBAurora Cannabis Inc
$ 7,72
(46,21%)
3,93M
ELEFSilver Elephant Mining Corp
$ 0,285
(26,67%)
321,42k
BUBurcon NutraScience Corporation
$ 0,12
(26,32%)
418,93k
WEEDCanopy Growth Corporation
$ 3,58
(21,77%)
6,69M
RTGRTG Mining Inc
$ 0,03
(20,00%)
6,02k
AOTAscot Resources Ltd
$ 0,14
(-24,32%)
5,43M
GMTNGold Mountain Mining Corp
$ 0,02
(-20,00%)
327,12k
WLLWWillow Biosciences Inc
$ 0,025
(-16,67%)
120,5k
FLNTFlint Corporation
$ 0,025
(-16,67%)
26,45k
ASNDAscendant Resources Inc
$ 0,05
(-16,67%)
80k
WEEDCanopy Growth Corporation
$ 3,58
(21,77%)
6,69M
AOTAscot Resources Ltd
$ 0,14
(-24,32%)
5,43M
ACBAurora Cannabis Inc
$ 7,72
(46,21%)
3,93M
TLRYTilray Brands Inc
$ 1,51
(4,14%)
3,84M
BTOB2Gold Corp
$ 3,64
(2,25%)
3,82M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock